`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`
`C. A. No. ______________
`
`
`
`
`Plaintiffs,
`
`Defendant.
`
`
`
`
`
` )
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`
`DAIICHI SANKYO, INC., DAIICHI SANKYO
`COMPANY, LIMITED, and ASTRAZENECA
`PHARMACEUTICALS LP,
`
`
`
`v.
`
`SEAGEN INC.,
`
`
`
`
`
`
`
`RULE 7.1 DISCLOSURE STATEMENT
`
`
`
`Pursuant
`
`to Federal Rule of Civil Procedure 7.1(a), Plaintiff AstraZeneca
`
`Pharmaceuticals LP hereby states that AstraZeneca PLC, a publicly-held company, is the
`
`ultimate parent company of AstraZeneca Pharmaceuticals LP. No other publicly-held
`
`corporation owns 10% or more of the stock of AstraZeneca Pharmaceuticals LP.
`
`DATED: November 13, 2020
`
`
`
`
`OF COUNSEL:
`
`David I. Berl
`Thomas S. Fletcher
`WILLIAMS & CONNOLLY LLP
`725 Twelfth St. NW
`Washington, DC 20005
`(202) 434-5000
`
`
`
`
`
`
`
`MCCARTER & ENGLISH, LLP
`
`/s/ Daniel M. Silver
`Michael P. Kelly (#2295)
`Daniel M. Silver (#4758)
`Alexandra M. Joyce (#6423)
`Renaissance Centre
`405 N. King Street, 8th Floor
`Wilmington, Delaware 19801
`(302) 984-6300
`mkelly@mccarter.com
`dsilver@mccarter.com
`ajoyce@mccarter.com
`
`Attorneys for Plaintiff AstraZeneca
`Pharmaceuticals LP
`
`{01625338;v1 }
`
`
`
`